Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study Of SU5416 With Androgen Ablation And Radiation In Patients With Intermediate and Advanced Stage Prostate Cancer

NCT00026377 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00026377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00026377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study Of SU5416 With Androgen Ablation And Radiation In Patients With Intermediate and Advanced Stage Prostate Cancer
Lead sponsor
University of Chicago
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2001
Completion date
April 30, 2003
Enrollment
3 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer